{"nct_id":"NCT01636843","title":"A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Methotrexate","status":"TERMINATED","status_verified_date":"2018-09","start_date":"2012-10-30","start_date_type":"ACTUAL","primary_completion_date":"2014-11-10","primary_completion_date_type":"ACTUAL","completion_date":"2014-11-10","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVO"]}